Summary

In this episode of the Med City Pivot Podcast, host Arundhati Parmar speaks with Lars Petersen about one of the most remarkable corporate transformations in modern business history.

Facing a catastrophic collapse of its core film business in the mid-2000s due to the rise of digital photography, Fujifilm executed a bold and strategic pivot into healthcare and life sciences. The company diversified aggressively, leveraging its deep expertise in materials science, imaging, and innovation to build a thriving biotechnology and medical technology ecosystem.

Today, Fujifilm operates as a global Contract Development and Manufacturing Organization (CDMO), partnering with leading pharmaceutical companies and startups alike. The conversation explores how strategic investment, diversification, long-term thinking, and innovation—including AI—enabled Fujifilm not just to survive, but to lead in a completely new industry.

Links & Resources

Keywords

Fujifilm Pivot Healthcare CDMO Biotechnology Biologics digital transformation business strategy Innovation AI in healthcare Pharma Manufacturing monoclonal antibodies gene therapy cell therapy Diversification corporate strategy MedTech

Episode Highlights

00:00–00:23 – Introduction to the concept of "pivot" and Fujifilm's survival story
00:00–00:47 – The collapse of the film industry and existential crisis
00:00–01:15 – Fujifilm's transformation into a healthcare company
00:02:39–00:03:28 – 2006: the pivotal year and 60% revenue loss
00:03:28–00:03:45 – Strategic decision to diversify long-term
00:04:22–00:05:08 – Why Fujifilm succeeded while competitors failed
00:05:35–00:06:26 – Key investments and acquisitions (including Biogen assets)
00:06:52–00:07:30 – Why healthcare is a stable, long-term growth industry
00:07:53–00:08:29 – Expansion into medical devices and imaging technologies
00:09:42–00:10:34 – Core therapeutic focus: biologics, gene therapy, cell therapy
00:10:49–00:11:22 – Serving both startups and global pharma giants
00:12:39–00:13:40 – Competitive positioning vs. Samsung Biologics & Lonza
00:15:08–00:15:44 – "Partners for life" philosophy and long-term trust
00:17:52–00:18:49 – AI integration across manufacturing ecosystems
00:18:54–00:19:42 – Final takeaway: building shared ecosystems for the future of medicine